Found vs. LillyDirect (Zepbound): prices, fine print, and the honest verdict

Tirzepatide pricing

On tirzepatide, Found is the cheaper program at $289 a month all-in versus LillyDirect (Zepbound)'s $449 — a gap of $160 a month, $1,920 a year, at the 10 mg maintenance basis. Found: $289 a month all-in at the 10 mg maintenance basis, flat at every dose from 2.5 to 15 mg, no membership fee. Prepaid terms bring the effective rate to $169/mo (12-month plan paid up front). LillyDirect (Zepbound): $449 a month all-in at the 10 mg maintenance basis, dose-scaled from a $299 entry, no membership fee. Prepaid terms reorder things: Found at $169/mo (12-month plan paid up front) — paid up front, with the regulatory-era caveat that locked-in months deserve a read of the refund terms first.

Semaglutide pricing

Only Found publishes a semaglutide price here: Semaglutide runs $289 a month all-in at the standing rate ($169 on intro/plan terms). LillyDirect (Zepbound) doesn't sell compounded semaglutide — its lane is brand fulfillment.

Different products, not just different prices

LillyDirect (Zepbound) fulfills the FDA-approved product — reviewed manufacturing, verified identity and sterility, stable legal status — while Found sells compounded medication: pharmacy-prepared, not FDA-reviewed, and operating under the narrower post-shortage pathways our legal guide tracks. The compounded discount is partly a risk premium; whether it's worth taking depends on the pharmacy behind it and your tolerance for regulatory turbulence.

Transparency

Found: Third-party-reported (verified 2026-08-05); dispensing pharmacy not publicly named. LillyDirect (Zepbound): Source-verified (verified 2026-08-09); names its pharmacy — Eli Lilly direct / retail partners. In this market, a named pharmacy and a dated, source-verified price are worth real money — they are what let you check the claim instead of trusting it.

Commitment & cancellation

Found: none month-to-month; prepaid terms for lowest rate; membership recurs; prepaid terms are paid up front. LillyDirect (Zepbound): 45-day refill cadence to keep pricing; no subscription; refill-window rules apply.

The gap, compounded over time

A $160/month difference sounds decidable by coin flip until it's annualized: choosing LillyDirect (Zepbound) over Found at the standing rates costs an extra one month, $160; six months, $960; a year, $1,920; two years of maintenance, $3,840. Only Found publishes a prepaid tier ($169/mo effective), which undercuts even LillyDirect (Zepbound)'s standing $449 by $3,360/year — flexibility versus committed savings, cleanly posed. Every figure is the all-in maintenance basis; the arithmetic reruns from the dataset.

The 24-month ledger

Zoom to the horizon that matters for a chronic-use drug — 24 months — and Found bills $6,936 and LillyDirect (Zepbound) $10,776, a spread of $3,840 for the same molecule at the same 10 mg basis. If prepaid terms held across both years, Found's $169 effective would total $4,056 — $2,880 under even the cheaper standing plan, with the standing caveat that two years of locked funds in this regulatory climate is a real bet, not a rounding choice. Reference rails for the same 24 months: $5,160 at the verified floor, $10,776 on brand Zepbound at maintenance, $8,376 on Wegovy flat.

Two ladders, side by side

The 2.5-to-10 mg climb is the honest stress test: Found holds $289 on every rung (four-month titration: exactly $1,156); LillyDirect (Zepbound) steps $299 → $399 → $449 and holds $449 from 7.5 mg up (four-month titration: $1,596). A flat ladder makes dose decisions purely clinical; a scaled one attaches an invoice to every escalation — including the post-plateau bump from 10 to 12.5 mg that many patients eventually face. Full framework: the titration cost guide.

Three buyers, two invoices

The month-one starter pays $289 at Found versus $299 at LillyDirect (Zepbound) for the 2.5 mg rung — a wash that the maintenance rates immediately un-wash. The settled 10 mg maintainer — the buyer our basis is built for — pays $3,468/year at Found against $5,388 at the other: $1,920 of annual daylight for the same molecule and dose. The committed prepayer does best at Found: $169/month effective, $2,028/year, funds up front, refund terms first.

The semaglutide board

Only Found fields a verified semaglutide price here — $289/month all-in (#14 of 19) — while LillyDirect (Zepbound) focuses its published pricing on tirzepatide. For a buyer starting on the cheaper molecule with a likely upgrade later, single-molecule programs mean a future re-shop; dual-molecule ones price the whole arc.

The five normalizations, applied to this pair

1 · All-in, not advertised. Found's ranked figure is $289, with no membership to add; LillyDirect (Zepbound)'s ranked figure is $449, with no membership to add. 2 · Maintenance basis. Found is dose-flat, so its entry and 10 mg figures coincide; LillyDirect (Zepbound) scales from $299 to $449, and the 10 mg figure is the one ranked. 3 · Terms separated. Found: standing $289, prepaid $169 effective (12-month plan paid up front); LillyDirect (Zepbound): standing $449, no prepaid tier — standing rates rank, prepaid effectives are labeled beside them. 4 · Evidence tiered. Found: third-party-reported, read 2026-08-05; LillyDirect (Zepbound): source-verified, read 2026-08-09. 5 · Pharmacy weighed. Found names no pharmacy; LillyDirect (Zepbound) names Eli Lilly direct / retail partners — in a pharmacy-variance market, disclosure is a scored asset. Run the same five on any roundup you read and most published “cheapest” lists reorder themselves.

Fine print, itemized

Found: no membership — the medication figure is the billed figure; prepaid 12-month plan paid up front at $169/mo effective; membership recurs; prepaid terms are paid up front; commitment: none month-to-month; prepaid terms for lowest rate. LillyDirect (Zepbound): no membership — the medication figure is the billed figure; no subscription; refill-window rules apply; commitment: 45-day refill cadence to keep pricing. The pattern to police on both sides is the same: memberships that outlive the medication order, renewal-relative cancellation deadlines, and prepaid terms whose refund language matters more than their discount in a year of live litigation. Cancel in writing; screenshot everything.

Transparency, audited

Found carries third-party-reported pricing (last read 2026-08-05); its dispensing pharmacy is not publicly named, so the five pharmacy questions (name, 503A/503B status, state licensure, certificate of analysis, formulation) are your pre-purchase homework. LillyDirect (Zepbound) carries source-verified pricing (last read 2026-08-09); pharmacy disclosure is its strong suit — Eli Lilly direct / retail partners, manufacturer direct. Our weighting is unapologetic: in a market of identical molecule names, a dated source-verified price and a named pharmacy are the two claims a buyer can actually check, and they carry 25 of 100 formula points between them — the methodology shows the math, and the pharmacy guide decodes every answer the five questions can return.

Switching between them

Neither program locks the door: a Found-to-LillyDirect (Zepbound) move is a new intake, a new prescription at the new pharmacy, and a written cancellation at the old shop — typically a one-to-two-week overlap if you time the last fill. What does not move with you: prepaid months, membership balances, and any dose paperwork, so re-state your current rung clearly at the new intake.

Refills, shipping, and the week-to-week reality

Past the pricing page, the operational facts are what a subscriber lives with: Found: shipping included; consultation included; async visit model. LillyDirect (Zepbound): shipping included (or same-day retail pickup); consultation bring your own prescription (telehealth partners available); prescription required visit model; a ~45-day refill cadence guards the self-pay tiers (lapse and fills reprice $599–$1,049 until re-enrollment). Cold-chain shipments run 3–7 days across the market; the recurring failure modes are refill-timing gaps and pharmacy backlogs, so whichever program wins here, order refills a week early and confirm the pharmacy’s current turnaround at intake.

Who should pick which

Pick Found if the $160/month tirzepatide saving is the point; you want a price that survives titration; you'll prepay for the $169 effective rate; you want the insurance paperwork done for you. Pick LillyDirect (Zepbound) if a named pharmacy is non-negotiable for you; only the FDA-approved product will do. Neither answer is universal — which is the argument for choosing from data with dates on it rather than from whichever ad loaded first.

If neither one fits

Two programs never exhaust the market — the nearest substitutes on the verified board are Fridays at $359 (flat, no membership); Lavender Sky Health at $352 (dose-scaled, $25 membership included); Henry Meds at $349 (flat, no membership) — or skip straight to the rankings page, where every standard “cheapest / best / no-commitment” question is answered in one sourced sentence.

The verdict

On the numbers alone, Found is the cheaper tirzepatide program by $160/mo ; LillyDirect (Zepbound)'s case rests on FDA-approved product, better pharmacy disclosure. Both records, with dates and sources, live in the pricing database.